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Abstract 
The health care delivery system of twenty five OECD nations is analyzed in this paper.  
This study seeks to assess the significance of various factors contributing to life 
expectancy and infant mortality for the 1990-2002 period. A fixed-effects panel data 
model was used to examine the factors influencing life expectancy and infant mortality. 
More specifically the impact of economic, institutional, and social factors in determining 
the dependent variables are measured and evaluated.  
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1.   INTRODUCTION 
 Expenditure on health and healthcare has escalated considerably in the OECD 
countries especially due to advancement and dissemination in medical technologies, 
population ageing and rising public demand.  Health expenditure as a percentage of GDP 
was around 8.5% in 2002.   In 1984, the average per capita health care expenditure of the 
OECD countries was $870 (with purchasing power parity adjustment). This figure rose to 
$2144 in 2002. Relative to the overall mean of the OECD countries, per capita health 
care expenditure growth has doubled compared to economic growth in the U.S. over the 
past 20 years. Lately, due to concerns over national security, there is an increasing trend 
in the OECD nations to reallocate resources from health care spending to expenditures 
related to security threats.   
Figure 1 shows the comparison of life expectancy and health care expenditures for 
OECD countries in 2002.  While trying to minimize healthcare costs, both developed and 
developing nations are making an effort to improve access to and quality of health care 
services for their citizens. Thus, identifying the relative role of various factors 
contributing to health care outcome is essential in understanding the issue and devising 
relevant policies to address it. 
 The majority of research on OECD health systems has focused on correlations 
between health care expenditures and economic performance of the member countries. 
These studies attempted to assess factors contributing to health using qualitative 
measures. Quantitative studies on the subject are limited, and a majority of the existing 
studies have used either time series or cross section analysis.   
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 The objective of this paper is to apply the panel data model to measure and assess 
the importance of factors determining the two commonly accepted measures of health 
care outcomes: life expectancy and infant mortality. In this study, the factors used as 
independent variables are divided into economic, institutional, and social aspects.   The 
aim of the study is to look at the comparative significance of each of the factors in 
determining life expectancy and infant mortality. The rest of the paper is structured as 
follows: section 2 presents a literature review and section 3 outlines the data and 
empirical methodology. Section 4 discusses the empirical findings, followed by 
conclusions in section 5. 
2.   LITERATURE REVIEW 
 The health care system plays a vital role in any economy as discussed in a study 
by Bloom et al. (2003).  There are studies that concentrated on the relationship between 
income inequality (using GDP per capita as a proxy) and health care in different countries 
(Preston, 1975; Deaton, 1999; Pritchett and Summers, 1996; Subramaniam et al, 2002; 
Asafu-Adjaye, 2004; Murthy, 2006; Cutler et al., 2006; Alsan et al., 2006). However, 
Bloom and Canning (2007) extended Preston’s (1975) work and questioned the 
appropriateness of using GDP per capita as a proxy for economic well-being.  In this 
study, health care expenditure is used as an alternative. 
There are a number of recent comparative analyses of health care systems in the 
literature. Among the studies, only a few focused on the correlations between health care 
outcomes; i.e., life expectancy and infant mortality, and the contributing elements such as 
institutional, economic and social factors.  None of the other OECD studies in the 
literature concentrated on these factors. 
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The magnitude of correlation between health care expenditure and GDP has been 
tested and reported by some published research.  MacDonald and Hopkins (2002) using 
the OECD samples, confirmed a strong correlation between the two variables cited above 
and suggest the presence of unit root in both GDP and health care expenditure data.  
Okunade et al. (2004) by calibrating annual growth rate of OECD health care expenditure 
data, tested the stationary nature of health care expenditure and illustrated the advantages 
of using jackknife re-sampling method for short time series. They further argue that the 
health care spending growth is driven by economic and institutional factors.  In addition, 
Carrion-I-Silvestre (2005) using OECD panel data, verified the presence of structural 
breaks for real per capita health care expenditures and real per capita GDP.  
To assess the elasticities of healthcare expenditure and GDP, Okunade and 
Suraratdecha (2000) used maximum likelihood estimates of the Box-Cox transformation 
regression model. They concluded that health care expenditures and GDP elasticities 
among OECD nations showed that health care is not a luxury commodity. A similar study 
by Anindya (2005) using OLS technique on OECD data for the period of 1990-98, 
confirmed the earlier findings of health care as being a non-luxury service among the 
fifteen-nation sample. Using health production function for the United States, Thornton 
(2002) contended that additional medical care utilization is ineffective on improving 
health as measured by life expectancy and mortality rate. Thus, this suggests that policies 
to promote health in the U.S. should focus on socioeconomic status and lifestyle. 
 Anderson and Hussey (2001) using OECD data focused on how performance of 
the health care systems varied among the twenty-nine members. In a five-nation (New 
Zealand, UK, US, Canada, and Australia) study, Blendon et al. (2003) found that a 
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significant number of citizens are unhappy with their health care system. Anell and Willis 
(2000) suggest that instead of expenditure measures, using a resource profile is more 
desirable alternative for an international comparison of health care systems. Anderson et 
al. (2003) revealed that differences in health care spending patterns between the U.S. and 
the rest of the OECD member nations are mostly explained by higher prices in the U.S.  
 Mirmirani and Mirmirani (2005) concentrated on the efficiency of OECD health 
care systems using Data Envelopment Analysis (DEA), a linear programming technique 
which ranked member nations according to their respective DEA scores. For the period of 
investigation (1990-2000), the efficiency results were mixed. Although some nations had 
high ranking in both measures of health care outcomes, none had been ranked as 
inefficient for both measures. On the other hand, some members have improved 
efficiency in life expectancy, but had done poorly in infant mortality, or visa versa.  
Evans et al. (2001), with a sample of 191 countries worldwide, conducted a comparative 
efficiency of national health care systems.  Using life expectancy as health output, and 
health expenditures and average schooling as inputs, they conclude that increasing 
resources result in improved health.  In addition, more efficient use of resources can also 
contribute to the overall health care of a nation.   Shaw et al. (2005) investigates the 
impact on changes in life style and pharmaceutical expenditure on life expectancies 
among OECD countries. With a specified cohort of the population; i.e., males and 
females at the age of 40 (for the period of 1960-1999), they find that increasing 
pharmaceutical expenditure, lowering tobacco consumption and increasing fruit and 
vegetable consumption have noticeable and positive but different impact on life 
expectancies of the observed population. 
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3.   EMPIRICAL METHODOLOGY 
3.1   Data and Variables 
The study uses data from OECD Health Data 2004. Annual data for the sample 
period of 1990-2002 were used.  Countries under investigation include all OECD 
member nations except Korea, Luxembourg, Norway, Slovak Republic and Turkey.  
These countries were excluded due to many missing observations.  The variables used in 
the regression and their definitions are given in this section. In the first regression, the 
dependent variable is life expectancy at birth for the total population. It was estimated 
using the unweighted average of life expectancy of men and women.  Life expectancy 
represents the typical number of years that a person at that age can be anticipated to live, 
presuming that age-specific mortality levels stay constant. In the second regression, the 
dependent variable is maternal and infant mortality.  It encompasses the number of deaths 
of children under one year of age that occurred in a given year, expressed per 1000 live 
births. 
The independent variables used in the regressions are: medical technology 
(computed tomography scanners per million populations), health employment (practicing 
physicians’ density per 1000 people), in-patient utilization per capita (number of acute 
care bed days), prevention immunization (% of measles children immunized 2000), total 
expenditure on health per capita (US$ PPP), alcohol consumption in litres per capita, and   
educational level (school expectancy years).  Table 1 and 2 provides acronyms, 
descriptions, expected signs, and justifications for using the variables in the two 
regressions.   Like alcohol consumption, another common factor that influences health 
status of any nation is the prevalence of smoking.  However, because of limitation on 
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data availability, we are unable to include any proxy of smoking in our study.  Also, we 
encountered similar constraint in incorporating measures of income inequality, i.e. GINI 
coefficient.  As indicated earlier in the literature review, using real GDP per capita for 
capturing inequality between nations may not be appropriate for this study (see Bloom 
and Canning (2007) for details).   
3.2   Regression Analysis 
For the panel data analysis, the data set consists of i = 1,…..,N cross sections 
(number of groups), and several points of time series for each group t = 1,….,T(i), or a 
cross section of N time series each of length T(i).  Panel data analysis can be divided into 
fixed effects (FE) and random effects (RE) models1.   FE model is also known as least 
squares with group dummy variables.  In the FE model, variation across groups 
(individuals) or time is confined in shifts of the regression function; i.e., changes in the 
intercepts. On the other hand, the RE model treats the individual effects as a random 
component of the error term.  The RE model assumes a structure on the error term, and a 
feasible generalized least-square technique determines the parameters.  The major 
drawback of the RE model is the assumption that the unobserved individual effect is 
uncorrelated with the observed regressors.  GLS estimation yields biased and inconsistent 
parameters in the presence of such correlation.  The RE model is appropriate when 
correlated omitted variables are not an issue. The estimation technique that best fit the 
data were chosen based on  Likelihood ratio, Breush and Pagan’s LM test, and 
Hausman’s Chi-squared statistics. The FE model turned out to be the best specification. 
The fixed effects regression specification was estimated in the form of: 
                                                 
1
   See Chamberlain (1982, 84), Hsiao (2004) and Baltagi (2005) for a comprehensive 
analysis of panel data. 
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Lit = η1 δ1it + η2 δ2it +……....+ β’ Qit   + µit      
where Lit is the average life expectancy (or infant mortality in the second 
regression)  in country i =1,……, N, year t = 1,….,T(i). 
Qit is the vector of independent variables. 
            δjit  is the group specific year dummy variables. 
ηi  is the individual specific constant or the country effect. 
µit is a classical disturbance term with E[µit] = 0, var[µit] = σ2µ . 
4.   EMPIRICAL RESULTS 
The primary goal of this study is to identify the determinants of life expectancy 
and infant mortality in the OECD countries.  In Table 3, regression results of the FE of 
life expectancy for 25 OECD countries are reported. Life expectancy was regressed on 
various independent variables using panel data. The signs of the parameter estimates of 
all the variables in the life expectancy regression were as expected.   Six of the seven 
variables (except ALCO) were statistically significant at the 5% level or better. Table 4 
presents regression results of the FE of infant mortality for 25 OECD countries. Three of 
the seven variables were statistically significant at the 5% level or better. With the 
exception of CT scan as a proxy for medical technology (TECH) and alcohol 
consumption (ALCO), all other variables in the infant mortality regression followed the 
expected sign. Nevertheless, neither of the two variables cited earlier were statistically 
significant at the 5% level.   
    Parameter estimate of health employment (PHYS) was strongly significant (at 1% 
level) in influencing life expectancy and infant mortality in OECD countries.    The 
empirical estimate of PHYS was the most significant in both regressions, which connote 
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that the availability of the health care personnel is really crucial. This indicates that larger 
number of physicians means better access to health services - especially in rural areas, 
and shorter waiting times for medical attention, lead to better health care delivery. Thus, 
investment in health related human capital especially physicians and nurses has a greater 
impact on improving life expectancy and reducing infant mortality.   Looking at the data, 
one observes significant differences in numbers of practicing doctors and nurses per 1000 
population among OECD countries, ranging from less than two to more than four.  Our 
empirical results indicate that scarcity of health related human capital will have a 
substantial adverse impact on life expectancy and infant mortality in many OECD 
countries. 
Preventive immunization (IMMUNI) was significant (at the 1% level) in both the 
regressions. However, immunization plays a more important role in reducing infant 
mortality than increasing life expectancy. The data showed that on average OECD 
countries only spend less than 3 percent of total health expenditure on preventive health 
awareness programs2.  Our regression results suggest that even with current low health 
expenditure on preventive medicine, such investment have a relatively high impact on 
influencing life expectancy and infant mortality. According to the OECD Indicators 
2005, awareness of better life-style alternative will significantly increase life expectancy.   
It is evident that 38% of people in OECD countries die because of heart diseases and 
strokes due to lack of public consciousness on diet, exercise and healthy food choice.  In-
patient utilization (PATIENT) as a proxy for health services utilized was a fairly 
                                                 
2
 Health at a Glance - OECD Indicators 2005 can be found at http://www.oecd.org/health/healthataglance 
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important factor in the life expectancy regression but statistically insignificant in the 
mortality regression. 
One would expect higher per capita health care expenditure would improve the 
overall health in the society.  Our empirical results indicate that the level of health care 
expenditure among OECD countries has been an important factor in extending life 
expectancy but does not have much impact on lowering infant mortality. Alcohol 
consumption (in litres per capita aged 15 and over) (ALCO) is commonly regarded as one 
of the health risk factors in the health care literature.   However, it is noteworthy that in 
our analysis, the estimates were not statistically significant at the 5% level in both 
regressions.  Perhaps one argument could be the fact that the methods in measuring 
alcohol consumption differ across OECD countries as mentioned in the data. As 
expected, educational level (EDU), used as an indicator of health awareness, was 
significant at the 5% level in both the regressions.  
5.   CONCLUSION 
 The majority of research papers on national health care systems have concentrated 
on the two commonly accepted outcomes, life expectancy and infant mortality.  
However, the OECD-focused studies tend to assess cross variations of the health 
outcomes among individual member nations. The limited number of existing studies that 
concentrated on the factors influencing life expectancy and infant mortality had some 
drawbacks. The studies were limited in their approach (qualitative) or scope (either time 
horizon or the number of countries investigated).   In this paper, we attempted to address 
the shortfalls mentioned above.  The concentration of the paper is for the period of 1990-
2002.  Running a time series analysis of individual countries for 12 years is not 
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statistically advisable (less than 30 sample size).  So, we decided to pool the data and run 
a panel data analysis for 25 OECD countries.   
Lately, social service provisions in industrialized nations such as education, 
defence, national security, social security and retirement plans draw considerable public 
attention. Significant and continuous rise in health care costs further add to the social and 
political tensions of the citizens.  Reform and restructuring of healthcare are among a few 
policy initiatives that these nations have been trying to implement as a way to control 
their health care industries.  Before devising any policy initiatives or restructuring plan, it 
is important to know the role of various factors that determine the health outcome.  
 Our goal was to be as inclusive as possible by incorporating independent variables 
that are relevant as well as considering variables from the existing health care literature. 
In choosing the variables, comprehensive factors that directly and indirectly (social) 
influence health care outcomes have been considered. However, some variables were 
dropped (smoking and GINI coefficient) due to missing data for the period of this study.  
 The panel data regression results provide some useful information on the 
healthcare assessment. For life expectancy as a dependent variable, supply of physicians, 
inpatient hospital bed days, overall financing of the health care, technology, preventive 
care, and education level, have played an important role. Judging from the regression 
coefficients, we concluded that the most influential factor is hospital bed days, followed 
by supply of physicians and education level. The proxy for social factor, alcohol 
consumption was not statistically significant. 
 However, for the infant mortality regression, empirical results were somewhat 
different. Physician supply, immunization and education are factors that were statistically 
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significant. This result follows the common perception that lowering the mortality rates 
require pre- and post-natal care and services. Among those, education, preventive care 
and availability of physicians are commonly cited in the literature. The estimated 
coefficients revealed that the most influential factor determining infant mortality rate is 
the supply of physicians, followed by the level of education and immunization. As in life 
expectancy regression, contrary to the findings of other studies, alcohol consumption is 
statistically insignificant in the infant mortality regression. One plausible explanation is 
the non-uniform definition and measure of alcohol consumption among OECD countries. 
The measurement complexity stems form the fact that different countries have varied 
consumption preferences for alcohol beverages.  For example, wine is preferred alcohol 
in France compare to beer in Germany.   Also, beverages have a different degree of 
alcohol contents within and among OECD countries. 
 The empirical results suggest that supply of physicians and education levels are 
highly significant and the determining factor in both the life expectancy and infant 
mortality regressions.  Policy implications that can be drawn from this study are as 
follows. One key component of improved health is education; particularly the education 
of mothers on child care and health, both in prenatal and neonatal stages. A recent study 
on infant mortality in the United States released by the US Department of Health and 
Human Services (2006) shows that comparatively mothers who received education on 
prenatal care had five times more chances for their babies to survive.   
This study confirmed that supply of physicians (particularly primary care 
physicians), and investment in medical training and education should be prioritize in the 
OECD national healthcare policy.   Emphasis on preventive care is another key element 
 12 
to improve healthcare in any given country.  According to a report by the World Medical 
Association (2005), among different aspects of preventive care, effective immunization 
policy plays a crucial role in the national healthcare system. 
Other policies that have direct link to the overall national health are those 
addresses social norms and practices. For example, Japan is ranked much higher on infant 
mortality rate and life expectancy than the United States. The disparity is explained by 
problems related to teenage pregnancy and obesity rates (CommonDreams.org, 2006). 
Dietary habits and more relaxed abortion regulations in Japan are cited as important 
factor explaining such disparities. Other social norms that contribute to the differences in 
the life expectancy and mortality among nations are policies on homicide and other 
serious crimes, environmental regulations, and social support for the elderly population.    
The selection of life expectancy and/or infant mortality as a proxy for health care 
outcome poses a challenge for researchers in the field. It has been noted that while a 
nation is receiving high marks for its achievements in prolonging life expectancy, they 
may be marginal on the infant mortality gains. This is of particular concern when such 
measures are used for international comparisons. For example, Mirmirani and Mirmirani 
(2005) consider the same health care outcomes as in this study and ranks efficiencies of 
OECD members. The study suggests that there may not be a correlation between the two 
outcomes. As a remedy, future research needs to concentrate on a single, uniform yet 
comprehensive health care outcome that is constructed from the available data.   
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Figure 1: Comparison of Life Expectancy at Birth and Health Expenditure in 
2002 for OECD Countries 
Source: OECD Health Data 2005, June 2005 
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Table 1: Variables, Descriptions, and the Relationships with Life Expectancy 
 
Acronym Description Expected 
sign 
Rationale 
TECH Medical technology -- 
computed tomography 
scanners per million 
population 
 
 
+ 
CT scan is a proxy for better 
access to disease diagnosis, 
thus higher life expectancy. 
PHYS Health employment --
practicing physicians 
density /1000 
 
 
+ 
Higher physician’s density, 
better health care for society. 
PATIENT In-patient utilization-- 
acute care bed days 
number per capita 
 
 
_ 
High in-patient utilization 
indicates poor health, which 
means lower life expectancy. 
IMMUNI Prevention Immunization-- 
measles % children 
immunized 2000 
 
 
+ 
Immunization is a preventive 
measure, increases life 
expectancy. 
HEXP Total expenditure  on 
health per capita (US$ 
PPP) 
 
 
+ 
Higher health expenditure 
will improve health services 
available, thus higher life 
expectancy. 
ALCO 
 
Alcohol consumption litres 
per capita (age 15+) 
_ High alcohol consumption 
implies high health risk, less 
life expectancy 
 
EDU Educational level School 
expectancy Years 
 
 
+ 
Higher literacy rate increases 
health awareness, therefore 
longer life expectancy. 
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Table 2: Variables, Descriptions, and the Relationships with Mortality 
 
Acronym Description Expected 
sign 
Rationale 
TECH Medical technology -- 
computed tomography 
scanners per million 
population 
 
 
_ 
Better access to medical 
technology results in lower 
mortality. 
PHYS Health employment --
practicing physicians 
density /1000 
 
 
_ 
More medical resources 
results in better health care 
for society, thus lower 
mortality. 
PATIENT In-patient utilization-- 
acute care bed days 
number per capita 
 
 
_ 
High in-patient utilization 
indicates poor health, leads 
to high mortality. 
IMMUNI Prevention Immunization-- 
measles % children 
immunized 2000 
 
 
_ 
Immunization as a proxy for 
preventive medicine results 
in lower mortality. 
HEXP Total expenditure  on 
health per capita (US$ 
PPP) 
 
 
_ 
Higher health expenditure 
will improve health services 
available, thus lower 
mortality. 
ALCO 
 
Alcohol consumption litres 
per capita (age 15+) 
 
+ 
 
High alcohol consumption 
implies higher health risk for 
mothers, therefore leads to 
high mortality. 
EDU Educational level School 
expectancy Years 
 
 
_ 
Higher literacy rate create 
better health awareness, 
therefore lower mortality. 
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Table 3: Empirical Results of Life Expectancy 
 
 Coefficient T-Statistics 
 
TECH 
 
0.0349** 
 
2.189   
  
 
PHYS 
 
1.2245*** 
 
4.806  
   
 
PATIENT 
 
-1.5172*** 
 
-4.835  
   
 
IMMUNI  
 
0.0213** 
 
2.551    
 
 
HEXP 
 
0.0004** 
 
2.015    
 
 
ALCO      
 
-0.0031 
 
-0.040    
 
 
EDU 
 
0.1851*** 
 
4.322    
 
R2 0.9845 
Adjusted R2 0.9796 
F-Value         202.28 *** 
           
               Note:   ***, and ** denotes significance at the 1%, and 5% levels respectively. 
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Table 4: Empirical Results of Infant Mortality 
 
 Coefficient T-Statistics 
 
TECH 
 
0.0459 
 
0.731  
   
 
PHYS 
 
-2.4649** 
 
-2.461  
   
 
PATIENT 
 
1.2225 
 
0.991    
 
 
IMMUNI   
 
-0.0819** 
 
-2.496   
  
 
HEXP 
 
-0.0002   
 
-0.273    
 
 
ALCO      
 
-0.0003       
 
-0.001   
 
 
EDU 
 
-0.4852*** 
 
-2.883   
  
R2 0.9322 
Adjusted R2 0.9109 
F-Value 43.89*** 
 
               Note:   ***, and ** denotes significance at the 1%, and 5% levels respectively. 
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